PharmaBoardroom

Hot Topics in US Healthcare & Pharma

So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…

Can the USA’s Fragmented Healthcare System Become More…

US healthcare is often seen as a fragmented system of contrasts. The country has the highest healthcare expenditures as a percentage of GDP and the…

Spain’s PharmaMar to Begin COVID-19 Trials for Aplidin

PharmaMar, a Spanish firm, is beginning Phase II clinical trials for its anti-tumour drug Aplidin to treat coronavirus. The firm’s stocks have…

Mohamed El Bouhmadi – President & CEO, Zenith Pharma,…

Mohamed El Bouhmadi, president and CEO of Zenith Pharma, walks us through the company’s evolution since we last met in 2015. He shares his strategy…

Sabena Solomon – General Manager, GSK Belgium, the…

Sabena Solomon, general manager of GSK Benelux, speaks about her first impressions of the Belgium market, having come from GSK Finland, and her…

Neil McMaster – General Manager Contract Logistics, GAC…

Neil McMaster, GAC Dubai’s General Manager Contract Logistics, discusses the key investments his company has made to stand out as the region’s…

Karel Van De Sompel – Country Manager, Pfizer Belgium…

Karel Van De Sompel, country manager of Pfizer in Belgium and Luxembourg and chairman of Pharma.be, highlights the key changes he sees in today’s…

Belgium Adopts Act Increasing the Transparency of Managed Entry…

On 16 April 2020, a new Act was adopted by the Belgian parliament to increase the transparency of managed entry agreements (‘MEA’) concluded…

Forging Connections & Trust – At A Safe Social…

Takeda’s Head of R&D Patient Engagement Jessica Scott examines the parallels between partnering with patients and working remotely with…

Marc Boutin – CEO, National Health Council, USA

Marc Boutin, JD, CEO of the National Health Council (NHC),* introduces the organization and its mission to provide a united voice for the 160 million…

Novartis: CAR-T’s Journey to Market in Europe

Two years on from the introduction of Novartis Oncology’s CAR-T therapy to Europe, Emnuele Ostuni, the firm’s European head of cell and gene…

Emanuele Ostuni – Head of Europe, Cell & Gene Therapy,…

Emanuele Ostuni, Novartis Oncology’s head of cell and gene therapy for Europe, gives an overview of the introduction of the company’s CAR-T…

Tagged with